Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer

PURPOSE: Preclinical models suggest that the use of anti–vascular endothelial growth factor (anti-VEGF) therapy with antiestrogens may prevent or delay the development of endocrine therapy resistance. We therefore performed a feasibility study to evaluate the safety of letrozole plus bevacizumab in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Traina, Tiffany A., Rugo, Hope S., Caravelli, James F., Patil, Sujata, Yeh, Benjamin, Melisko, Michele E., Park, John W., Geneus, Stephanie, Paulson, Matthew, Grothusen, Jill, Seidman, Andrew D., Fornier, Monica, Lake, Diana, Dang, Chau, Robson, Mark, Theodoulou, Maria, Flombaum, Carlos D., Norton, Larry, Hudis, Clifford A., Dickler, Maura N.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2010
Sujets:
ORIGINAL REPORTS
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3940895/
https://ncbi.nlm.nih.gov/pubmed/19841327
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.21.8784
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires